MedTech News
.................... by Andrew Celentano
Virtual patients could help flag medical device risks missed by conventional studies
University of Manchester–led researchers have unveiled a roadmap for making computer-generated evidence trustworthy enough to help regulators decide whether medical devices are safe and effective, alongside laboratory and clinical evidence.
Candy-coated Lollylab checks saliva for medication
What if checking medication levels were as simple as enjoying a lollipop? A candy-coated device called Lollylab could provide the answer. In ACS Sensors, researchers describe how the lollipop’s stem transfers saliva to a sensor that measures acetaminophen levels.
Abbott receives FDA approval for new CardioMEMS HF System capabilities
ABBOTT PARK, Ill., Oct. 5, 2026 /PRNewswire/ — Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) approval for updates to the CardioMEMS HF System that enable new patient-facing capabilities through the CardioGuide HF App.
New technology advances understanding of eye pressure and glaucoma
For millions of people at risk of glaucoma, healthy eye pressure can mean the difference between preserving vision and losing it. Yet despite decades of research, scientists still do not fully understand what regulates daily changes in eye pressure or how those fluctuations may contribute to glaucoma.
Brain tissue removed during surgery reveals potential way to curb inflammation linked to Alzheimer’s
Inflammatory conditions in the brain, including traumatic brain injury and degenerative diseases like Alzheimer’s, could be targeted with an existing drug thanks to new research that shows it can work in brain cells.
Magnetically controlled capsule shows promise for investigating hard-to-reach regions of the small intestine
A small capsule could change how we study the microbiome of the small intestine. A team led by researchers at the University of Tokyo has created a pill-shaped device designed to take samples from the small intestine using a tiny extendable brush.
RNA urine test outperforms standard bladder cancer tests and could help guide treatment
A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System can diagnose bladder cancer more accurately than current standard methods. The test also allows physicians not only to assess the cancer’s response to treatment but also to predict whether immunotherapy or chemotherapy is likely to be most effective for each patient.
Inflammation can reactivate ‘sleeping’ cancer cells hidden in the bone
The spread of cancer from a primary tumor to another place in the body, called metastasis, remains one of the greatest challenges in cancer treatment and is responsible for most cancer-related deaths.